Raytheon Intelligence & Space, a key business segment of Raytheon Technologies Corp. (NYSE: RTX), has been awarded a significant contract worth $372,137,000 by the Naval Air Warfare Center Weapons Division. 

The contract entails updates, improvements, and enhancements to tactical capabilities, sensor instrumentation, and instrumentation interfaces for F/A-18 and EA-18G software blocks. 

In after-hours, $RTX was trading at $98.80, down $0.28 or 0.28%.

Sientra, Inc. (Nasdaq: SIEN) has received FDA clearance for its revolutionary AlloX2 Pro Tissue Expander. 

The AlloX2 Pro sets itself apart by eliminating 95% of the metal traditionally used in tissue expander ports. As a result, it has received an MRI-conditional label, making it the only tissue expander in the United States approved for exposure to magnetic resonance imaging. Additionally, the AlloX2 Pro boasts other innovative features such as minimal interference with radiation therapy, faster port filling and drainage, and a softer drain for improved patient comfort. 

Following the announcement, $SIEN experienced a significant increase of $1.34 (+76.57%) in after-hours, trading at $3.09

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)